We evaluated demographics and risk factors for ZIKV infection among organ donors and transplant outcomes among recipients of donors with positive ZIKV testing. One 
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| INTRODUCTION
Zika virus (ZIKV) is a mosquito-borne arbovirus that has caused outbreaks in Africa, Southeast Asia, and the Pacific Islands. ZIKV has been associated with complications such as congenital microcephaly and fetal loss among infected pregnant women, and neurologic complications such as Guillain-Barré syndrome, myelitis, meningoencephalitis, and peripheral neuropathy. [4] [5] [6] [7] [8] [9] Fatalities associated with ZIKV have been reported. 10, 11 ZIKV transmission through blood transfusion has been confirmed. 12 The risk of transmission through organ donation is unknown. 13 Nogueira et al reported the first series of ZIKV infection in solid organ transplant (SOT) recipients including two liver and two kidney transplant recipients from Brazil.
The liver and kidney recipients were diagnosed 43 and 115 days and 61 and 590 days post-transplantation, respectively. It is unknown if these patients received their organs from ZIKV-infected donors as there was no available donor data.
14 Infected patients are usually viremic for 7-10 days. 13 ZIKV RNA persists significantly longer in whole blood than in plasma. 15 In one small study, 6 patients had urinary shedding ranging 10 days to >20 days. 16 An investigation in Florida suggested that urine PCR might be the most sensitive test to diagnosis acute infection in symptomatic patients due to higher and more prolonged detection rates of ZIKV.
17
It is not known how long ZIKV can be detected in tissue. 
| MATERIAL AND METHODS

| Study design
This is a single center retrospective study conducted at Jackson Demographics, risk factors for ZIKV and a ZIKV questionnaire were obtained. DonorNet was reviewed to obtain these data. We assessed whether there were differences between donors who tested positive for ZIKV and those who did not. We have included the ZIKV protocol created by our transplant infectious diseases group to provide guidance on the safe use of organs from deceased donors that test positive for ZIKV (see Data S1). Although this guideline could not be validated prior to implementation, it delineates the management protocol adopted at our center during a time of active local ZIKV transmission.
| Rates of positive ZIKV serology and PCR
ZIKV IGM and IGG and plasma and urine PCR results of all local deceased donors tested from June 2016 to January 2017 were obtained and analyzed. The ZIKV serology used in our study was EUROIMMUN Anti-ZIKV enzyme-linked immunosorbent assay (ELISA) IGM and IGG which is commercially available through Thermo Fisher Scientific, Inc., and it was validated in our laboratory to be performed manually, and it has a specificity of 93% and a sensitivity of 40%. 20 Our laboratory used the RealStar Zika Virus RT-PCR Kit by Altona that has a sensitivity and specificity of 91% and 97%, respectively. 21 The extraction method was either by NucliSENS, easyMag, or manual extraction using the Qiagen RNA Blood Mini Kit. ZIKV serology and PCR were tested in all the local deceased donors at the time of their initial evaluation along with HLA typing, ABO and other serology testing. The turnaround time for ZIKV serology and PCR was three to four hours. 
| Demographics
| Risk factors for ZIKV
Risk factors for transmission of ZIKV include exposure to Aedes mosquitoes in an endemic region or sexual contact with an infected individual. We collected data about travel to ZIKV-endemic countries within 6 months prior to donation and occupation, as outdoor occupations are more likely to be associated with mosquito exposure. Patients who lived in ZIKV-endemic countries within 6 months prior to donation were also considered as travelers. Donor data with respect to sex with people who had traveled to ZIKV-endemic countries was not available.
| ZIKV questionnaire
We reviewed the responses of the ZIKV questionnaire from the donors' family members. The questionnaire included three questions:
1. Was the donor told by a doctor that she/he had ZIKV?
2. Did the donor have a pink eye or joint pain recently?
3. Did the donor travel abroad within 6 months prior to transplant?
The latter question was included in the section of risk factors for ZIKV.
| Differences between ZIKV-positive and ZIKV-negative local deceased donors
We evaluated for differences in demographics, risk factors for ZIKV and ZIKV questionnaire findings between donors who tested positive
for ZIKV and those who tested negative.
| Transplant outcomes among recipients of local deceased donors with positive ZIKV testing
We investigated whether the recipients of donors with positive ZIKV testing developed rejection, graft failure or death or symptoms suggestive of ZIKV by 6 months posttransplant.
| Statistical analyses
Chi square and Fisher's exact tests were used as appropriate to assess bivariate associations between categorical variables; Student's t-test or Mann-Whitney test were used to compare continuous variables between groups, depending on normality of the distributions. A P < .05 was considered significant.
| RESULTS
| Study population
A total of 167 local deceased donors were screened for ZIKV. Of those, 25 were excluded as their UNOS match ID # was not available.
Therefore, 142 donors were analyzed. None of the patients excluded had a positive ZIKV test. 
| Rates of positive ZIKV serology and PCR
| Demographics
The mean age was 39.7 ± 16.7 years. Ninety (63%) donors were male, 112 (79%) were Caucasians, 43 (30%) were Hispanics and 98 (69%) donors were born in the US (Table 1 ). The majority came from Lucie and it was unclear for the other. The donors who came from the ZIKV zones had negative ZIKV testing.
| Risk factors for ZIKV
| Travel to ZIKV-endemic countries
Fourteen (10%) local deceased donors traveled to ZIKV-endemic countries within 6 months prior to donation. These included Mexico (1 week in 1 donor and 3 days in another), Haiti (1 week in 1 donor and duration not specified in another), St. Thomas and St. Maarten (1 week), Bahamas (3 days), Argentina (1 week), Trinidad (unclear duration), Caribbean (duration and location not specified) and the Philippines (10 days). Two donors moved from Jamaica (2 and 3 months prior to donation), 1 from Dominican Republic (1 month prior) and 1 moved from Brazil (4 months prior to donation). The donors that traveled to Haiti (duration not specified) and moved from Jamaica 2 months prior to donation were ZIKV IGG positive. had indoor occupations, 40 (28%) were unemployed and in 9 (6%) of the donors it was not clear if the occupation was indoors or outdoors.
| Occupations
| ZIKV questionnaire
The questionnaire was answered for 116 (82%) of the donors. None responded that they were told by a doctor that she/he had ZIKV or recent pink eye or joint pain.
| Differences between ZIKV-positive and ZIKV-negative local deceased donors
Although not statistically significant, ZIKV IGG-positive local deceased donors were less likely to have been born in the US and more likely to have traveled to ZIKV-endemic countries within 6 months prior to organ donation compared to ZIKV-negative donors ( 
| Transplant outcomes among recipients of local deceased donors with positive ZIKV testing
The two kidneys from a ZIKV IGG-positive local deceased donor were transplanted at our hospital. Neither of the recipients had rejection, graft failure or death nor developed symptoms suggestive of ZIKV by 6 months posttransplant. ZIKV testing was not performed in these recipients as per our ZIKV protocol (see Data S1) since the donor had negative ZIKV IGM and ZIKV PCR from plasma and urine. None of Cover campaign to encourage residents to remove or cover standing water in the neighborhoods. 27 Only 19% of the donors were outdoor workers. Given the aggressive mosquito control, it is unlikely that the number of ZIKV-positive results would have been significantly higher if more donors were outdoor workers. The CDC has issued recommendations to employers and employees to protect outdoor workers from acquiring ZIKV.
28
The very low rate of ZIKV infection in deceased donors at our cen- 29 Therefore, studies evaluating the need for testing kidney recipients of ZIKV IGG-positive donors to evaluate for asymptomatic seroconversion are needed.
Our study has limitations. The relatively small cohort limited the ability to achieve statistical significance in some of the analyses.
Larger studies including more patients in the ZIKV-positive group and using the PRNT assay to differentiate ZIKV from other flaviviruses easier to obtain in living donor studies.
In conclusion, our study demonstrated a low prevalence of ZIKV among local deceased donors and indicates that ZIKV IGG-positive local deceased donors were more likely to have traveled to ZIKVendemic countries within 6 months prior to donation. In addition, this small cohort suggests that outcomes in recipients of ZIKV IGGpositive donors are excellent.
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